Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital

ÖZDEMİR, KEVSER; BAYSAL, Birol; KARADAĞ, ÖMER; TEMİZ, Hakan; BİLMAN, Fulya; Kaya, Safak

Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital

Şafak KAYA, (SB Diyarbakır Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Diyarbakır, Türkiye)

Birol BAYSAL, (Bezmialem Vakıf Üniversitesi, Tıp Fakültesi, Gastroenterology Anabilim Dalı, İstanbul, Türkiye)

Hakan TEMİZ, (SB Diyarbakır Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Diyarbakır, Türkiye)

Ömer KARADAĞ, (Hacettepe Üniversitesi, Tıp Fakültesi, Romatoloji Anabilim Dalı, Ankara, Türkiye)

Kevser ÖZDEMİR, (Acıpayam Devlet Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Denizli, Türkiye)

Fulya BİLMAN (Sağlık Bakanlığı, İzmir Menemen Devlet Hastanesi, Mikrobiyoloji Laboratuvarı, İzmir, Türkiye)

Viral Hepatitis Journal

1 1

Yıl: 2014 Cilt: 20 Sayı: 3 Sayfa Aralığı: 120 - 124 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital

Öz:

Amaç: Türkiyenin güneydoğusunda bir eğitim hastanesine başvuran hastalardahepatit B ve C seroprevalansını araştırmak. Gereç ve Yöntemler: Şubat 2010-Temmuz 2011 arasında Diyarbakır Eğitim veAraştırma Hastanesine başvuran hastalar retrospektif olarak değerlendirildi.Hepatit B ve C testi yapılan tüm hastalar çalışmaya dahil edildi. Veriler hastanemizinveri tabanından elde edildi ve SPSS programı kullanılarak analiz edildi. Bulgular: Hepatit B surface antijeni (HBsAg) bakılan toplam 43,131 hastadeğerlendirildi. HBsAg pozitif olan 4472 (%10,4) hastanın %6,8i erkek, %3,2sikadındı (p<0,05). Hepatit C virüs antikoru (anti-HCV) bakılan 28,276 hastanın 323ü(%1,2) pozitifti. HBeAg bakılan 2,899 hastanın 381i (%13,1) pozitifti. Sonuç: Güneydoğuda HCV seroprevalansı Türkiyenin diğer bölgelerine benzeroranda olmasına rağmen, hepatit B seroprevalansı hala yüksek orandadır. HepatitB enfeksiyonunun geçişi ve önlenmesi konusunda halkın farkındalığı halk eğitimleriverilerek güçlendirilmelidir.

Anahtar Kelime:

Konular: Gastroenteroloji ve Hepatoloji

Bir Eğitim Hastanesine Başvuran Hastalar Arasında Hepatit B ve C Seroprevalansı

Öz:

Objectives: To evaluate seroprevalence of hepatitis B virus (HBV) and hepatitis Cvirus (HCV) among patients admitted to a tertiary hospital in southeast Turkey. Materials and Methods: A retrospective study of patients admitted to theDiyarbakır Training and Research Hospital during February 2010 and July 2011. Thestudy population consisted of patients who gave blood and tested for HBV and HCV.Data were collected from the database of our hospital. Data were analyzed usingSPSS program. Results: A total of 43.131 patients tested for hepatitis B surface antigen (HBsAg)were included in this study. 4.472 patients (10.4%) were positive for HBsAg (6.8%male, 3.6% female, p<0.05). 323 (1.2%) of 28.276 patients, who underwent anti-HCVtesting, were positive for anti-HCV. 381 (13.1%) of 2.899 HBsAg-positive patientswere positive for hepatitis B e antigen (HBeAg). Conclusion: Although similar to that in the other regions of Turkey, theseroprevalence of hepatitis B is still high. Community awareness about thetransmission and prevention of hepatitis B infection should be strengthened byhealth education.

Anahtar Kelime:

Konular: Gastroenteroloji ve Hepatoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. World health organization. Western Pacific regional plan for hepatitis B control through immunization. Philippines: Regional office for the Western Pacific Manila; [http://www.wpro.who. int/publications/publications.htm]. accessed 5 January 2009.
2. Sorrell MF, Belongia ea, Costa J, Gareen IF, Grem Jl, Inadomi JM, kern eR, Mchugh Ja, Petersen GM, Rein MF, Strader DB, Trotter hT. national Institutes of health Consensus Development Conference Statement: Management of hepatitis B. ann Intern Med. 2009; 150(2): 104-110.
3. lok aS, McMahon BJ. Chronic hepatitis B. hepatol. 2007; 13: 507-539.
4. Gacche Rn, al-Mohani Sk. Seroprevalence and Risk Factors for hepatitis C virus Infection among General Population in Central Region of Yemen. hepat Res Treat .2012; 2012: 689726.
5. aygen B. hepatitis a virus. In: Willke Topcu a, Söyletir G, Doğanay M editors: Infectious Diseases and Microbiology. İstanbul; 2002.
6. Degertekin h, Gunes G. horizontal transmission of hepatitis B virus in Turkey. Public health. 2008; 122(12): 1315-1317.
7. Tabak F. acute viral hepatitis. In: Tabak F editor. Infectious Diseases. İstanbul; 2003.
8. kıyan M. hepatitis B virus. In: Tekeli e, Balık I, editors. viral hepatitis. İstanbul; 2003.
9. Mıstık R. viral hepatitis epidemiology in Turkey. In: Tabak F, Balık I, Tekeli e, editors. viral hepatitis. İstanbul: 2007.
10. erden S, Buyukozturk S, Calangu S. hBsag, anti-hBs and anti- hCv seropositivity In outpatients (In Turkish) J Turkish Society for Microbiol. 2000; 30: 131-134.
11. kurt h, Battal I, Memikoglu o, Yesilkaya a, Tekeli e. Distribution of hav, hBv, hCv Seropositivity by age and sex of healthy individuals in the ankara region (In Turkish). J viral hepat. 2003; 2: 88-96.
12. kacar, F, erol S, Parlak M, kadanalı a. Seroprevalence of hepatitis B virus and around erzurum (In Turkish). J Infect. 2003; 17: 389-393.
13. Tosun YS, özacar T, zeytinoğlu a, Tavmergen e, Bilgiç a. Infertility, hepatitis a, hepatitis B, and hepatitis C seroprevalence (In Turkish). Med network Clinical Sci 2003; 9(2): 215-219.
14. kacmaz B. Seroprevalence of hepatitis B and hepatitis C infection in ankara (In Turkish). J viral hepat. 2003; 2: 97-101.
15. Tekay F, özbek e. hepatitis B, hepatitis C and human immunodeficiency virus seropositivity among women admitted to Sanlıurfa obstetrics and Gynecology hospital (In Turkish). Microbiol newsletter. 2006; 40: 369-373.
16. Tekay F. hBv, hCv and hIv seroprevalence in hakkari (In Turkish). J Dicle Med. 2006; 33: 170-173.
17. Demirturk n, Demirdal T, Toprak D, altindis M, aktepe oC. hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks. Turk J Gastroenterol. 2006; 17(4): 267- 272.
18. Sacar S, asan a, Toprak S, Gez aD, Çatak B, Turgut h. evaluation hBsag Seropositivity in acıpayam where is widespread Tobacco workmanship (letter to the editor) (In Turkish) Microbiol newsletter. 2007; 41(1): 163-164.
19. Madendag Y, Col Madendag I, Celen S, unlu S, Danisman n. hepatit B, hepatit C ve hIv seroprevalence admitted to our hospital (In Turkish) J Gynecol obst. 2007; 17: 442-446.
20. karaca B, Tarakcı h, Tümer e. Seroprevalence of hBsag in İzmir (In Turkish). J viral hepat. 2007; 12: 91-94.
21. asan a, Sacar S, Catak B, karahasanoğlu FB, zencir M, Turgut h. Seroprevalence of hBsag in Denizli (In Turkish). J viral hepat. 2007; 12(1): 40-48.
22. Yildirim B, Barut S, Bulut Y, Yenisehirli G, ozdemir M, Cetin I, etikan I, akbas a, atis o, ozyurt h, Sahin S. Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: a population-based study. Turk J Gastroenterol. 2009; 20(1): 27-30.
23. kurdoglu z, efe S. hepatitis B, hepatitis C and hIv seroprevalence of women in van (In Turkish). J van Med. 2009; 16(4): 128-130.
24. akcam z, akcam M, Coşkun M, Sumbul M. evaluation of knowledge about viral hepatitis and hepatitis B vaccine of health workers (In Turkish). J viral hepat. 2003; 8: 32-35.
25. Motor vk, evirgen o, aksakal M, Incı M, onlen Y, ocak S. hepatitis B and C seropositivity among women admitted to hatay Maternity and Child Care hospital (In Turkish). J viral hepat. 2010; 16: 53-56.
26. Tunc n, eraydın h, Cetinkaya e, oduncu Mk, Toy S. hBsag, anti-hBs, anti- hCv ve anti-hIv seroprevalence in patients admitted to Siirt State hospital (In Turkish). J viral hepat. 2011; 17: 7-11.
27. Gunal o, Barut hS, Tetikcok R, Celtek nY, etikan I. Seroprevalence of hepatitis B virus (hBv), hepatitis C virus (hCv) and human immunodeficiency virus (hIv) in preoperative patients admitted to a hospital in northern anatolia. african J Microbiol Res. 2011; 5(31): 5669-5673.
28. kandemir o, Goksu M, kurt o. hepatitis B and C Frequency in Mersin Province urban District and City Center (In Turkish). J viral hepat. 2011; 17(2): 69-73.
29. Baryaman eS, aslan M, Saltoglu n, Yakar h, kocazeybek B, Samastı M. evaluation of hepatitis B seroprevalence in trades and municipal workers, hepatitis Certification Training Study (In Turkish). J viral hepat. 2011; 17(1): 16-21.
30. Coskun eI, Dincgez B, koyuncu RG, ayanoglu YT, Yumru ae. hBsag, anti-hBs and anti-hCv prevalence among pregnant women (In Turkish). J Perinatol. 2011; 19(5): 102.
31. Demirpence o, Tezcan SI, Degirmen e, Mert D, Gumus a, Celen Mk. hepatitis and hIv serology results in patients admitted to Batman State hospital (In Turkish). J viral hepat. 2012; 18: 6-10.
32. Cetinkol Y. hBsag, anti-hCv and anti-hIv seroprevalence admitted to hakkari State hospital (In Turkish). J viral hepat. 2012; 18(2): 76-80.
33. Cicek aC, Inakcı h, Duygu F. hepatitis B and C seroprevalence among women admitted to Şanlıurfa obstetrics and Gynecology hospital: Three-Year evaluation (In Turkish). J viral hepat. 2012; 18: 15-8.
34. Tasyaran Ma. hepatitis B epidemiology. Tekeli e, Balık I, editors. viral hepatitis. İstanbul: 2003.
35. Bilgic a, ozacar T. hepatitis B virusu. In: Willke Topcu a, Soyletir G, Doganay M, editors. Infect Dis and Microbiol. İstanbul: 2002.
36. Dursun M, ertem M, Yılmaz S, Saka G, ozekinci T, Simsek z. Prevalence of hepatitis B infection in the southeastern region of Turkey: Comparison of risk factors for hBv infection in rural and urban areas. Jpn J Infect Dis. 2005; 58: 15-9.
37. karabay o, Serin e, Tamer a, Gökdoğan F, alpteker h, ozcan a et al. hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: a prospective epidemiologic study. Turk J Gastroenterol. 2004; 15: 11-3.
38. Demir I, kaya S, Demirci M, Cicioglu-arıdoğan B. Investigate the seroprevalence of hepatitis B virus in health care workers Isparta (In Turkish). J Infect. 2006; 20: 183-187.
39. lau Gk, Wang FS. Management of chronic hepatitis B e antigen-negative disease: another step forward. J Infect Dis. 2012; 1: 7-9.
40. hadziyannis SJ, vassilopoulos D. hepatitis B e antigen-negative chronic hepatitis B. hepat. 2001; 34: 617-624.
41. Funk Ml, Rosenberg DM, lok aS. World-wide epidemiology of hBeag-negative chronic hepatitis B and associated precore and core promoter variants. J viral hepat. 2002; 9: 52-61.
42. Shepard CW, Finelli l, alter MJ. Global epidemiology of hepatitis C virus infection. lancet Infect Dis. 2005; 5(9): 558- 567.
43. uzun o. viral hepatitis epidemiology. In: uzun o, unal S, editors.. Infectious diseases in light of current knowledge. ankara: 2002. p.6.
44. Dikici B, Bosnak M, haspolat k. The prevalence of anti-hCv seropositivity among children in Turkey. J Clin virol. 2002; 24(1- 2): 135-136.

APA	Kaya S, BAYSAL B, TEMİZ H, KARADAĞ Ö, ÖZDEMİR K, BİLMAN F (2014). Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. , 120 - 124.
Chicago	Kaya Safak,BAYSAL Birol,TEMİZ Hakan,KARADAĞ ÖMER,ÖZDEMİR KEVSER,BİLMAN Fulya Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. (2014): 120 - 124.
MLA	Kaya Safak,BAYSAL Birol,TEMİZ Hakan,KARADAĞ ÖMER,ÖZDEMİR KEVSER,BİLMAN Fulya Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. , 2014, ss.120 - 124.
AMA	Kaya S,BAYSAL B,TEMİZ H,KARADAĞ Ö,ÖZDEMİR K,BİLMAN F Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. . 2014; 120 - 124.
Vancouver	Kaya S,BAYSAL B,TEMİZ H,KARADAĞ Ö,ÖZDEMİR K,BİLMAN F Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. . 2014; 120 - 124.
IEEE	Kaya S,BAYSAL B,TEMİZ H,KARADAĞ Ö,ÖZDEMİR K,BİLMAN F "Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital." , ss.120 - 124, 2014.
ISNAD	Kaya, Safak vd. "Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital". (2014), 120-124.

APA	Kaya S, BAYSAL B, TEMİZ H, KARADAĞ Ö, ÖZDEMİR K, BİLMAN F (2014). Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. Viral Hepatitis Journal, 20(3), 120 - 124.
Chicago	Kaya Safak,BAYSAL Birol,TEMİZ Hakan,KARADAĞ ÖMER,ÖZDEMİR KEVSER,BİLMAN Fulya Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. Viral Hepatitis Journal 20, no.3 (2014): 120 - 124.
MLA	Kaya Safak,BAYSAL Birol,TEMİZ Hakan,KARADAĞ ÖMER,ÖZDEMİR KEVSER,BİLMAN Fulya Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. Viral Hepatitis Journal, vol.20, no.3, 2014, ss.120 - 124.
AMA	Kaya S,BAYSAL B,TEMİZ H,KARADAĞ Ö,ÖZDEMİR K,BİLMAN F Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. Viral Hepatitis Journal. 2014; 20(3): 120 - 124.
Vancouver	Kaya S,BAYSAL B,TEMİZ H,KARADAĞ Ö,ÖZDEMİR K,BİLMAN F Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital. Viral Hepatitis Journal. 2014; 20(3): 120 - 124.
IEEE	Kaya S,BAYSAL B,TEMİZ H,KARADAĞ Ö,ÖZDEMİR K,BİLMAN F "Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital." Viral Hepatitis Journal, 20, ss.120 - 124, 2014.
ISNAD	Kaya, Safak vd. "Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital". Viral Hepatitis Journal 20/3 (2014), 120-124.